INVO Fertility, Inc. Common Stock logo

INVO Fertility, Inc. Common Stock (IVF) Q1 2025 Annual Earnings

IVF·Reported May 20, 2025·Before market open

INVO Fertility, Inc. Common Stock reported Q1 2025 revenue of $1.6M (+3.9% YoY), beat analyst consensus of $1.6M by $31.2K. Diluted EPS came in at $-300.75 (-71507.1% YoY), missed the $-14.40 consensus by $286.35.

Revenue
$1.6Mbeat by $31.2K
Consensus: $1.6M
Diluted EPS
$-300.75missed by $286.35
Consensus: $-14.40
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0001641172-25-006726

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about INVO Fertility, Inc. Common Stock's Q1 2025 earnings report.

INVO Fertility, Inc. Common Stock (IVF) reported Q1 2025 earnings on May 20, 2025 before market open.

INVO Fertility, Inc. Common Stock reported revenue of $1.6M and diluted EPS of $-300.75 for Q1 2025.

Revenue beat the consensus estimate of $1.6M by $31.2K. EPS missed the consensus estimate of $-14.40 by $286.35.

Compared to the same quarter a year prior, revenue grew 3.9% from $1.6M a year earlier and diluted EPS declined 71507.1% from $-0.42.

You can read the 10-K periodic report (0001641172-25-006726) directly on SEC EDGAR. The filing index links above go to sec.gov.